Today: 21 March 2026
Subscribe
Browse Category

NASDAQ:DAWN 13 November 2025

Mersana Therapeutics (MRSN) Soars on Up to $285 Million Day One Biopharmaceuticals Buyout: All the Key News on November 13, 2025

Mersana Therapeutics (MRSN) Soars on Up to $285 Million Day One Biopharmaceuticals Buyout: All the Key News on November 13, 2025

Day One Biopharmaceuticals will acquire Mersana Therapeutics in a deal valued at up to $285 million, offering $25 per share in cash plus contingent value rights up to $30.25 per share. Mersana’s board and major holders support the agreement. MRSN shares jumped as much as 200% pre-market. Halper Sadeh LLC launched a shareholder fairness investigation.
13 November 2025
···

Stock Market Today

  • Rocket Companies (RKT) Valuation Examined After Share Price Drop
    March 20, 2026, 9:43 PM EDT. Rocket Companies (RKT) saw its share price fall to $13.65, down over recent weeks despite a 31.34% year-to-date gain. The company, operating in the U.S. and Canadian financial sector with mortgage and real estate services, faces a market cap near $41.3 billion. Recent acquisitions of Mr. Cooper and Redfin aim to create a one-stop home buying and mortgage platform. While the stock's 1-year total return is flat and net losses at $68 million persist, analysts rate the stock undervalued with a fair value around $40.00. This optimistic valuation hinges on successful integration and a booming housing market. Risks include weakened housing activity and acquisition challenges, suggesting investors weigh rewards against uncertainties amid mixed sentiment.
Go toTop